drugset / Trial / NCT01214174
Efficacy and Safety Study of IBI-10090 in Cataract Surgery Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will test the efficacy and safety of IBI-10090 in the treatment of ocular inflammation after cataract surgery.
Timeline
- Start
- 2010-10
- Primary completion
- 2012-05
- Completion
- 2012-05
Outcome
Outcome not reported
Stopped: “Study C11-01 started”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IBI-10090 | Unknown | 513 ug | — |
| Subject | IBI-10090 | Unknown | 776 ug | — |
| Subject | IBI-10090 | Unknown | 1046 ug | — |
Indications
No indication recorded.